Jacques Fourgeaud

2.4k total citations · 1 hit paper
23 papers, 1.0k citations indexed

About

Jacques Fourgeaud is a scholar working on Infectious Diseases, Epidemiology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Jacques Fourgeaud has authored 23 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Infectious Diseases, 12 papers in Epidemiology and 5 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Jacques Fourgeaud's work include Cytomegalovirus and herpesvirus research (10 papers), Parvovirus B19 Infection Studies (7 papers) and Herpesvirus Infections and Treatments (4 papers). Jacques Fourgeaud is often cited by papers focused on Cytomegalovirus and herpesvirus research (10 papers), Parvovirus B19 Infection Studies (7 papers) and Herpesvirus Infections and Treatments (4 papers). Jacques Fourgeaud collaborates with scholars based in France and United States. Jacques Fourgeaud's co-authors include Pierre Frange, Julie Toubiana, François Angoulvant, Jérémie F. Cohen, Romain Basmaci, Slimane Allali, Agathe Debray, Jean‐Laurent Casanova, Fanny Bajolle and Clément Poirault and has published in prestigious journals such as PEDIATRICS, Clinical Infectious Diseases and Scientific Reports.

In The Last Decade

Jacques Fourgeaud

19 papers receiving 986 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Kawasaki-like multisystem inflammatory syndrome in children during the covid-19 pandemic in Paris, France: prospective observational study

2020 737 citations Julie Toubiana, Clément Poirault et al. BMJ profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jacques Fourgeaud France	9	558	534	275	207	171	23	1.0k
Steven Welch United Kingdom	15	575 1.0×	332 0.6×	357 1.3×	115 0.6×	81 0.5×	39	1.0k
Shana Godfred‐Cato United States	13	388 0.7×	532 1.0×	89 0.3×	195 0.9×	140 0.8×	34	923
Agathe Debray France	5	397 0.7×	517 1.0×	73 0.3×	161 0.8×	170 1.0×	6	774
L. Douglas Smith United States	2	437 0.8×	675 1.3×	70 0.3×	208 1.0×	185 1.1×	2	868
Clément Poirault France	3	403 0.7×	529 1.0×	60 0.2×	172 0.8×	170 1.0×	15	765
Elodie Salvador France	2	395 0.7×	515 1.0×	59 0.2×	155 0.7×	170 1.0×	4	742
Marilyn McDougall United Kingdom	6	661 1.2×	970 1.8×	149 0.5×	323 1.6×	268 1.6×	14	1.4k
Anne Ferris United States	7	287 0.5×	647 1.2×	75 0.3×	234 1.1×	108 0.6×	13	774
Priyen Shah United Kingdom	3	687 1.2×	1.1k 2.1×	111 0.4×	353 1.7×	306 1.8×	3	1.4k
Adriana Tremoulet United States	6	690 1.2×	1.2k 2.2×	112 0.4×	367 1.8×	306 1.8×	7	1.5k

Countries citing papers authored by Jacques Fourgeaud

Since Specialization

Citations

This map shows the geographic impact of Jacques Fourgeaud's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacques Fourgeaud with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacques Fourgeaud more than expected).

Fields of papers citing papers by Jacques Fourgeaud

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jacques Fourgeaud. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacques Fourgeaud. The network helps show where Jacques Fourgeaud may publish in the future.

Co-authorship network of co-authors of Jacques Fourgeaud

This figure shows the co-authorship network connecting the top 25 collaborators of Jacques Fourgeaud. A scholar is included among the top collaborators of Jacques Fourgeaud based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jacques Fourgeaud. Jacques Fourgeaud is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fourgeaud, Jacques, et al.. (2026). Occult rat hepatitis E virus infection as a cause of cirrhosis and posttransplant recurrence: insights into the role of metagenomics. American Journal of Transplantation.

Fourgeaud, Jacques, Marianne Burgard, Slimane Allali, et al.. (2025). Virological characterization of Parvovirus B19 isolated during the atypical 2023-2024 outbreak in France. Journal of Infection. 90(2). 106409–106409. 3 indexed citations

Fourgeaud, Jacques, et al.. (2025). Cytomegalovirus Vertical Transmission Rate According to IgG Avidity Value and Valacyclovir Treatment of Maternal Primary Infection in the First Trimester of Pregnancy. Clinical Infectious Diseases. 81(5). e417–e423.

Chatzakis, Christos, et al.. (2025). The effect of valacyclovir on secondary prevention of congenital cytomegalovirus infection. Best Practice & Research Clinical Obstetrics & Gynaecology. 103. 102679–102679.

Fourgeaud, Jacques, Pascal Turlure, Sophie Alain, et al.. (2025). Remdesivir for the Treatment of Human Coronavirus OC43 Encephalitis. Journal of Medical Virology. 97(3). e70314–e70314.

Riller, Quentin, et al.. (2024). Protective role of antibodies in enteric virus infections: Lessons from primary and secondary immune deficiencies. Immunological Reviews. 328(1). 243–264. 2 indexed citations

Fourgeaud, Jacques, et al.. (2024). In utero treatment of congenital cytomegalovirus infection with valganciclovir: an observational study on safety and effectiveness. Journal of Antimicrobial Chemotherapy. 79(10). 2500–2508. 3 indexed citations

Fourgeaud, Jacques, et al.. (2023). Comparison of two serological screening strategies for cytomegalovirus primary infection in the first trimester of pregnancy. Journal of Clinical Virology. 169. 105614–105614. 5 indexed citations

Pérot, Philippe, Jacques Fourgeaud, Claire Rouzaud, et al.. (2023). Circovirus Hepatitis Infection in Heart-Lung Transplant Patient, France. Emerging infectious diseases. 29(2). 286–293. 19 indexed citations

10.

Fourgeaud, Jacques, Jean‐François Magny, Sophie Couderc, et al.. (2022). Clinical Value of Serial Quantitative Analysis of Cytomegalovirus DNA in Blood and Saliva Over the First 24 Months of Life in Congenital Infection: The French Cymepedia Cohort. The Journal of Pediatrics. 253. 197–204.e5. 12 indexed citations

11.

Fourgeaud, Jacques, Audrey Mirand, Louis Collet, et al.. (2022). Enterovirus meningitis in Mayotte French Comoros Island, March-June 2019. Journal of Clinical Virology. 150-151. 105154–105154. 5 indexed citations

12.

Morel, Antoine, Sandrine Imbeaud, Anne Scemla, et al.. (2022). Severe relapse of SARS-CoV-2 infection in a kidney transplant recipient with negative nasopharyngeal SARS-CoV-2 RT-PCR after rituximab. American Journal of Transplantation. 22(8). 2099–2103. 12 indexed citations

13.

Pardinhas, Clara, Anne Jamet, Jacques Fourgeaud, et al.. (2022). Renal arcuate vein thrombosis–induced acute kidney injury: a rare multiple-Hit–mediated disease. Clinical Kidney Journal. 16(2). 367–373. 2 indexed citations

14.

Contejean, Adrien, Étienne Canouï, Jacques Fourgeaud, et al.. (2021). Transmission Routes of Severe Acute Respiratory Syndrome Coronavirus 2 Among Healthcare Workers of a French University Hospital in Paris, France. Open Forum Infectious Diseases. 8(3). ofab054–ofab054. 5 indexed citations

15.

Faure‐Bardon, Valentine, Jacques Fourgeaud, Tiffany Guilleminot, et al.. (2021). First‐trimester diagnosis of congenital cytomegalovirus infection after maternal primary infection in early pregnancy: feasibility study of viral genome amplification by PCR on chorionic villi obtained by CVS. Ultrasound in Obstetrics and Gynecology. 57(4). 568–572. 18 indexed citations

16.

Faure‐Bardon, Valentine, Jacques Fourgeaud, J. Stirnemann, Marianne Leruez‐Ville, & Y. Ville. (2021). Secondary prevention of congenital cytomegalovirus infection with valacyclovir following maternal primary infection in early pregnancy. Ultrasound in Obstetrics and Gynecology. 58(4). 576–581. 55 indexed citations

17.

LeGoff, Jérôme, Solen Kernéis, Caroline Elie, et al.. (2021). Evaluation of a saliva molecular point of care for the detection of SARS-CoV-2 in ambulatory care. Scientific Reports. 11(1). 21126–21126. 16 indexed citations

18.

Fourgeaud, Jacques, Julie Toubiana, Hélène Chappuy, et al.. (2021). Impact of public health measures on the post-COVID-19 respiratory syncytial virus epidemics in France. European Journal of Clinical Microbiology & Infectious Diseases. 40(11). 2389–2395. 93 indexed citations

19.

Mizrahi, Assaf, Najoua El Helali, Jacques Fourgeaud, et al.. (2021). The Coris BioConcept COVID 19 Ag Respi-Strip, a field experience feedback. Journal of Virological Methods. 300. 114366–114366. 3 indexed citations

20.

Toubiana, Julie, Clément Poirault, Fanny Bajolle, et al.. (2020). Kawasaki-like multisystem inflammatory syndrome in children during the covid-19 pandemic in Paris, France: prospective observational study. BMJ. 369. m2094–m2094. 737 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact